Sun Pharma to acquire 85% in Russian firm Biosintez for $24 million - Livemint
×
Home Companies Industry Politics Money Opinion Budget 2018 LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday
×